Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,089 | -6,391 | -4,039 | -2,911 | -1,517 |
| Depreciation Amortization | 3 | 43 | 35 | 28 | 6 |
| Accounts payable and accrued liabilities | 86 | 158 | 68 | 372 | 320 |
| Other Working Capital | 14 | 627 | 290 | 471 | 626 |
| Other Operating Activity | -316 | 579 | 100 | -253 | -266 |
| Operating Cash Flow | $-1,301 | $-4,985 | $-3,547 | $-2,294 | $-831 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | -4 | -2 | -2 | N/A |
| Other Investing Activity | 0 | 0 | -2,004 | -2,002 | 0 |
| Investing Cash Flow | $-5 | $-4 | $-2,006 | $-2,004 | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | 5,543 | 2,229 | 2,229 | 2,229 |
| Financing Cash Flow | $0 | $5,543 | $2,229 | $2,229 | $2,229 |
| Beginning Cash Position | 6,029 | 5,475 | 5,475 | 5,475 | 5,475 |
| End Cash Position | 4,723 | 6,029 | 2,151 | 3,406 | 6,873 |
| Net Cash Flow | $-1,306 | $554 | $-3,324 | $-2,069 | $1,398 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,301 | -4,985 | -3,547 | -2,294 | -831 |
| Capital Expenditure | -5 | -4 | -2 | -2 | 0 |
| Free Cash Flow | -1,306 | -4,989 | -3,549 | -2,296 | -831 |